Collaborative Specialty Care for Gulf War Syndrome
Trial Summary
What is the purpose of this trial?
Gulf War Veterans (GWVs) with Gulf War Illness (GWI) do not receive the care they should in the Veterans Affairs (VA). The investigators' data show 70% of GWVs with Gulf War Illness (GWI) do not receive treatment recommendations for their GWI and 78% are NOT very satisfied with their care. The quality of care GWVs receive must improve. VA and DoD have invested hundreds of millions of dollars to develop new treatments for GWVs, without effective delivery methods GWVs will not benefit. This study will be the first study to examine the best model of care to deliver treatments to GWVs with GWI. Determining the best model of care to translate research into practice is a key goal of the VA Gulf War Strategic Plan and a specific aim of this Request for Applications.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Collaborative Specialty Care for Gulf War Syndrome?
Research shows that collaborative care models, like those used for cancer and depression, improve care coordination and patient satisfaction. For example, a study at Virginia Mason Medical Center demonstrated that collaboration among healthcare providers improved treatment quality and reduced costs for conditions like headaches, suggesting potential benefits for similar approaches in managing Gulf War Syndrome.12345
Is Collaborative Specialty Care safe for humans?
The safety of Collaborative Specialty Care, including its use for Gulf War Syndrome, is not directly addressed in the available research articles. However, similar multidisciplinary care models have been used internationally for chronic pain and have shown stable improvements in various health outcomes, suggesting a general level of safety.678910
How is the Collaborative Specialty Care treatment for Gulf War Syndrome different from other treatments?
The Collaborative Specialty Care treatment is unique because it involves a multidisciplinary team approach, where various healthcare professionals work together to provide coordinated care, similar to models used for managing complex conditions like depression and genetic disorders. This approach emphasizes collaboration and communication among specialists, which can improve patient outcomes and satisfaction.511121314
Research Team
Lisa Marie McAndrew, PhD
Principal Investigator
East Orange Campus of the VA New Jersey Health Care System, East Orange, NJ
Scott E. Sherman, MD MPH
Principal Investigator
VA NY Harbor Healthcare System, New York, NY
Justeen K Hyde, PhD
Principal Investigator
VA Bedford HealthCare System, Bedford, MA
Eligibility Criteria
This trial is for Gulf War Veterans who served in Operation Desert Shield/Storm and meet the Kansas City (Steele) definition of Gulf War Illness. They should experience pain that limits their activities, rating at least a 3 out of 10 on a pain scale, and must have a VA primary care provider. Those with suicidal intent or previous specialized evaluations or participation in related trials are excluded.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive health coaching and problem-solving treatment, with monthly optimization of analgesics in collaborative specialty care or a onetime recommendation in e-consultation
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Collaborative Specialty Care (Behavioral Intervention)
- e-consultation (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor